Previous 10 | Next 10 |
2023-11-06 11:57:05 ET Protalix Biotherapeutics, Inc. (PLX) Q3 2023 Earnings Conference Call November 6, 2023 8:30 AM ET Company Participants Chuck Padala - Managing Director, Investor Relations Dror Bashan - President and Chief Executive Officer Eyal Rubin - Sen...
2023-11-06 10:01:49 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...
2023-11-06 08:17:52 ET Losers: MoonLake Immunotherapeutics ( MLTX ) -30% . Tecnoglass ( TGLS ) -15% after Q3 earning release . Kodiak Sciences ( KOD ) -11% says Phase 3 trial for lead asset met key goals. Arrival ( ARVL ) -9% . A...
2023-11-06 06:53:00 ET More on Protalix BioTherapeutics Protalix BioTherapeutics Stock Is A Hold Pending Successful Commercialization Of Elfabrio Nano-X, InMode, Teva among notable Israel-based healthcare decliners Seeking Alpha’s Quant Rating on Protalix BioT...
2023-10-31 15:49:03 ET A New Jersey-based %Healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This report came one day following the company’s announcement that it will be rele...
2023-10-31 12:24:58 ET Summary Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rare diseases. The company recently received FDA approval for its combination therapy Pombiliti + Opfolda for Pompe disease. Amicus Therapeutics i...
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023 PR Newswire Company to host conference call and webcast at 8:30 a.m. EST CARMIEL, Israel , Oct. 30, 2023 /PRNewswire/ -- Protalix BioTherapeutic...
2023-10-20 10:06:59 ET More on Health Care: Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the...
2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...
2023-10-09 08:23:30 ET More on InMode, Mirati Therapeutics, etc. InMode: Bullish Support Failed To Materialize InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks InMode: Be Greedy When Others Are Fearful Bristol-Myers Squibb to acquire...
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
Protalix BioTherapeutics Inc. Website:
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout PR Newswire Event will take place on Wednesday, June 26, 2024 in New York CARMIEL, Israel , J...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....